Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 3

1(25.0%)

Phase 2

1(25.0%)

4Total

N/A(2)

Phase 3(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT04330131Not ApplicableWithdrawn

TMW Community-Wide Demonstration Project

Role: collaborator

NCT04357730Phase 2Completed

Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection

Role: collaborator

NCT01766037Not ApplicableCompleted

Pivotal Aspiration Therapy With Adjusted Lifestyle Therapy Study

Role: collaborator

All 4 trials loaded